Target intelligence / Profile preview

Linker histone H1 family and associated chromatin loci (H1)

Target
H1
Molecular classification
Histone, DNA-binding protein, Chromatin-associated protein, Epigenetic regulator
01

Overview

Linker histone H1 variants are a family of essential proteins that facilitate the organization of higher-order chromatin structure by binding to the linker DNA between nucleosomes. These variants, including H1.0 through H1.5 and H1x, are critical for stabilizing the 30-nm fiber and regulating the accessibility of specific chromatin loci to the transcriptional machinery (UniProt, 2024). Beyond their structural role, H1 variants function as dynamic regulators of gene expression, DNA repair, and cell differentiation, with specific variants often localizing to distinct genomic regions such as heterochromatin or active promoters (PubMed: 29107537). In various diseases, particularly cancer, the expression patterns of H1 variants are frequently altered, contributing to epigenetic reprogramming and tumor progression (PubMed: 30554877). For example, H1.0 is often downregulated in undifferentiated cancer cells, while specific mutations in H1.4 are associated with Rahman syndrome, a neurodevelopmental disorder (NIH, 2023). Therapeutic strategies targeting H1 variants involve small molecules that disrupt H1-DNA binding or modulate post-translational modifications, though achieving variant-specific targeting remains a significant challenge due to the high conservation and ubiquitous nature of these proteins (PubMed: 34206055).

Other names
Histone H1Linker histonesH1 variantsH1.0-H1.5H1xH1tH1ooH1.0H1.1H1.2H1.3H1.4H1.5
02

Mechanism of action

Modulation of chromatin accessibility and higher-order structure through the displacement or stabilization of linker histones at specific genomic loci to alter gene expression and DNA damage responses.

03

Biological functions

Chromatin compactionTranscriptional regulationDNA repairApoptosisCell differentiationCell cycle regulation
04

Disease associations

CancerNeurodevelopmental disordersAutoimmune diseaseRahman syndromeSystemic lupus erythematosus
05

Safety considerations

Global chromatin instabilityOff-target epigenetic effectsSystemic toxicity due to ubiquitous expressionDisruption of essential DNA repair mechanisms
06

Interacting drugs

Quinacrine

3 more in the full profile.

07

Biomarkers

H1.0 expression levelsH1.2 cytosolic translocationH1 phosphorylation statusH1.4 mutation status

Beyond the preview

Go deeper on Linker histone H1 family and associated chromatin loci (H1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Linker histone H1 family and associated chromatin loci (H1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call